Trial · NCT03013543
Adverse events3,680
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 3,680
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Skin Hyperpigmentation | Skin and subcutaneous tissue disorders | 16p11.2 Cohort | 17 | 19 | |
| other | Skin Hyperpigmentation | Skin and subcutaneous tissue disorders | AS Cohort | 3 | 4 | |
| other | Skin Hyperpigmentation | Skin and subcutaneous tissue disorders | BBS Cohort | 8 | 10 | |
| other | Skin Hyperpigmentation | Skin and subcutaneous tissue disorders | MC4R Cohort | 40 | 49 | |
| other | Skin Hyperpigmentation | Skin and subcutaneous tissue disorders | POMC/PCSK1/LEPR Heterozygous Cohort | 19 | 33 | |
| other | Skin Hyperpigmentation | Skin and subcutaneous tissue disorders | POMC/PCSK1/LEPR Composite Heterozygous Cohort | 3 | 5 | |
| other | Skin Hyperpigmentation | Skin and subcutaneous tissue disorders | POMC/PCSK1/LEPR Compound Heterozygous Cohort | 21 | 27 | |
| other | Skin Hyperpigmentation | Skin and subcutaneous tissue disorders | SH2B1 Cohort | 16 | 22 | |
| other | Skin Hyperpigmentation | Skin and subcutaneous tissue disorders | SMS Cohort | 10 | 12 | |
| other | Skin Hyperpigmentation | Skin and subcutaneous tissue disorders | SRC1 Cohort | 23 | 32 | |
| other | Macule | Skin and subcutaneous tissue disorders | 16p11.2 Cohort | 0 | 19 | |
| other | Macule | Skin and subcutaneous tissue disorders | AS Cohort | 0 | 4 | |
| other | Macule | Skin and subcutaneous tissue disorders | BBS Cohort | 0 | 10 | |
| other | Macule | Skin and subcutaneous tissue disorders | MC4R Cohort | 2 | 49 | |
| other | Macule | Skin and subcutaneous tissue disorders | POMC/PCSK1/LEPR Heterozygous Cohort | 3 | 33 | |
| other | Macule | Skin and subcutaneous tissue disorders | POMC/PCSK1/LEPR Composite Heterozygous Cohort | 0 | 5 | |
| other | Macule | Skin and subcutaneous tissue disorders | POMC/PCSK1/LEPR Compound Heterozygous Cohort | 0 | 27 | |
| other | Macule | Skin and subcutaneous tissue disorders | SH2B1 Cohort | 2 | 22 | |
| other | Macule | Skin and subcutaneous tissue disorders | SMS Cohort | 3 | 12 | |
| other | Macule | Skin and subcutaneous tissue disorders | SRC1 Cohort | 2 | 32 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03013543/events